← Back to Search

Pilot participants for Dementia (ADVANCE-PC Trial)

N/A
Waitlist Available
Led By Annette M Totten, PhD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months after start of program
Awards & highlights

ADVANCE-PC Trial Summary

This trial is testing a new way to provide training and support to primary care clinicians who care for patients with dementia, using a remote technology called ECHO. The trial will assess whether this new method is feasible and acceptable, and whether it leads to improved outcomes for patients with dementia.

Eligible Conditions
  • Dementia
  • Advance Care Planning

ADVANCE-PC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months after start of program
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months after start of program for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of enrolled participants who attend 80% of ECHO program sessions
Proportion of patients with dementia and/or their care partners seen by participating clinicians who are engaged in ACP.
Secondary outcome measures
Participating clinician satisfaction rating: questionnaire designed for this study
Percentage of enrolled participants who plan to continue to engage patients with dementia in ACP

ADVANCE-PC Trial Design

1Treatment groups
Experimental Treatment
Group I: Pilot participantsExperimental Treatment1 Intervention
Participants will participate in ADVANCE-PC training via ECHO and will receive practice facilitation support, if needed. To assess the feasibility of the ADVANCE-PC training and implementation support, research data will be collected from participating clinicians at three time points. Two data collection points will be pre and post ECHO program training questionnaires about attitudes, experience, and intentions related to ACP and dementia. The third will be an interview at the end of the follow-up period, focusing on barriers to and facilitators of ACP in the context of dementia and the impact of the training and implementation support. Feasibility and acceptability of this intervention will be evaluated using descriptive and qualitative analyses of these data.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
970 Previous Clinical Trials
6,845,921 Total Patients Enrolled
12 Trials studying Dementia
1,248 Patients Enrolled for Dementia
University of Colorado, DenverOTHER
1,731 Previous Clinical Trials
2,144,580 Total Patients Enrolled
6 Trials studying Dementia
5,153 Patients Enrolled for Dementia
Annette M Totten, PhDPrincipal InvestigatorOregon Health and Science University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Advance Care Planning (ACP) in Primary Care for Dementia
Annette Totten 2022. "Advance Care Planning (ACP) in Primary Care for Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05322317.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top